Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2023 Jul;42(7):917-918.
doi: 10.1007/s10096-023-04612-x. Epub 2023 Apr 29.

Ceftriaxone for methicillin-susceptible Staphylococcus aureus (MSSA) bacteremia: a matter of dosages?

Stefano Di Bella  1 , Milo Gatti  2   3 , Luigi Principe  4
Affiliations
Free article
Comment

Ceftriaxone for methicillin-susceptible Staphylococcus aureus (MSSA) bacteremia: a matter of dosages?

Stefano Di Bella et al. Eur J Clin Microbiol Infect Dis. 2023 Jul.
Free article
No abstract available

PubMed Disclaimer

Comment on

References

    1. Yetmar ZA, Khodadadi RB, Go JR, Chesdachai S, Abu Saleh OM (2023) Post-treatment outcomes of ceftriaxone versus antistaphylococcal penicillins or cefazolin for definitive therapy of methicillin-susceptible Staphylococcus aureus bacteremia. Eur J Clin Microbiol Infect Dis 42:423–430 - DOI - PubMed
    1. Online document. https://www.eucast.org/fileadmin/src/media/PDFs/EUCAST_files/Breakpoint_... . Accessed 19 Mar 2023
    1. Telles JP, Leme RCP, Campos ML, Ito C, Bail L, Nogueira KDS et al (2021) Ceftriaxone and methicillin-susceptible : a perspective from pharmacokinetics/pharmacodynamics studies. Expert Opin Drug Metab Toxicol 17:1039–1048 - DOI - PubMed
    1. Zelenitsky SA, Beahm NP, Iacovides H, Ariano RE, Zhanel G (2018) Limitations of ceftriaxone compared with cefazolin against MSSA: an integrated pharmacodynamic analysis. J Antimicrob Chemother 1(73):1888–1894 - DOI
    1. Heffernan AJ, Sime FB, Lim SMS, Adiraju S, Wallis SC, Lipman J et al (2022) Pharmacodynamics of ceftriaxone for the treatment of methicillin-susceptible Staphylococcus aureus: is it a viable treatment option? Int J Antimicrob Agents 59:106537 - DOI - PubMed

MeSH terms